Browsing Tag
Astellas US
2 posts
Dr. Reddy’s Laboratories launches FDA-approved Regadenoson Injection in the US market
Dr. Reddy’s Laboratories has launched its FDA-approved generic Regadenoson Injection in the US, offering a cost-effective alternative to Lexiscan for cardiac imaging.
Can Glenmark Pharmaceuticals’ tentative FDA nod for Regadenoson Injection boost its US generics momentum?
Glenmark Pharmaceuticals secures FDA tentative approval for Regadenoson Injection, targeting a USD 660M U.S. cardiac stress agent market.